• SENSEX 75,615.60
    -679.76 (--0.89%)
  • BANKNIFTY 51,597.35
    249.30 (+0.49%)
  • Tata Motors
    613.20 606.20(%)
  • Hindalco Inds.
    608.00 558.00(%)
  • Hind.Aeronautics
    4,205.05 3,045.95(%)
  • Reliance Industr
    1,192.85 1,156.00(%)
  • Mazagon Dock
    2,542.50 995.38(%)
  • Vedanta
    403.50 297.70(%)
  • Interglobe Aviat
    5,150.65 5,187.00(%)
  • Infosys
    1,451.50 1,359.10(%)
  • HDFC Bank
    1,842.20 1,880.00(%)
  • Bajaj Finance
    8,795.75 9,258.95(%)
  • ICICI Bank
    1,336.40 1,372.50(%)
  • Suzlon Energy
    55.00 37.95(%)
  • Vodafone Idea
    7.85 6.60(%)
  • TCS
    3,307.55 3,396.10(%)
  • Jio Financial
    222.30 198.60(%)
  • Angel One
    2,317.80 1,942.00(%)
  • O N G C
    225.70 215.20(%)
  • Kalyan Jewellers
    485.80 337.00(%)
  • IndusInd Bank
    675.40 605.40(%)
  • Nippon ETF Liq.
    999.99 996.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Ipca Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 3617.0
  • ISIN : INE571A01038
1,497.60 82 (5.77%)
  • As on 04 Apr 2025 (EOD)

  • Today’s Low

    1,430.95

  • Today’s High

    1,515.15

  • Open

    1,430.95

  • Perv Close

    1,415.95

  • 52W Low

    1,052.00

  • 52W High

    1,755.90

Key Indicators

  • P/E(TTM)

    45.83

  • Mar.Cap (₹Cr.)

    37,994.74

  • Div & Yield %

    0.27

  • Book Value(₹)

    265.61

  • Debt-Equity Ratio

    5.77

  • AGM Date

    03-Apr-2025

  • EPS

    32.66

  • P/E Ratio

    45.83

Financials Ratios

  • Debt-Equity Ratio

    0.24

  • Mar.Cap (₹Cr.)

    37,994.74

  • RONW (%)

    8.69

  • ROCE (%)

    12.92

Score Board

  • Equity (₹ in Cr.)

    25.37

  • BV (₹)

    265.60

  • Sales( ₹ in Cr.)

    6,166.46

  • NP (in Cr.)

    599.93

  • NP Var(%)

    23.0

  • Div%

    400.0

  • CPS (₹)

    33.40

  • EPS (₹)

    23.60

  • Traded Value (₹ in Lakhs)

    37,975.72

  • 52 Week High

    1,755.90

  • 52 Week Low

    1,052.00

  • Price BSE

    1497.0

  • Price NSE

    1,498.00

  • Market Capital( in Cr.)

    37,975.72

  • P/C Ratio

    44.90

  • P/E Ratio

    63.30

  • Price Vs.BV

    23.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 6,166.46 5,814.62 5,438.30 5,139.16 4,367.43 3,633.15
Excise Duty 6,114.14 5,770.73 5,368.17 5,077.30 4,302.75 3,577.94
Net Sales 6,166.46 5,814.62 5,438.30 5,139.16 4,367.43 3,633.15
Other Income 111.29 111.19 52.92 62.24 64.69 54.59
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 6,277.75 5,925.81 5,491.22 5,201.40 4,402.51 3,660.25
EXPENDITURE :
Raw Materials 6,114.14 5,770.73 5,368.17 5,077.30 4,302.75 3,577.94
Power & Fuel Cost 6,114.14 5,770.73 5,368.17 5,077.30 4,302.75 3,577.94
Employee Cost 1,336.19 1,193.39 1,102.14 948.84 870.79 752.24
Other Manufacturing Expenses 183.42 238.73 182.84 116.30 152.46 144.91
Selling & Administrative Expenses 846.95 812.67 612.89 551.23 523.99 511.56
Miscellaneous Expenses 183.42 238.73 182.84 116.30 152.46 144.91
Less : Pre-operative Expenses Capitalised :
Total Expenditure 5,322.23 5,175.32 4,417.11 3,821.44 3,617.54 3,102.86
Operating Profit 610.14 588.95 516.47 426.73 395.12 344.03
Interest 120.67 43.92 7.24 8.14 15.79 18.49
Gross Profit 822.16 750.49 1,074.11 1,379.96 784.97 557.39
Depreciation 246.48 228.63 209.65 187.72 178.69 171.88
Profit Before Tax 822.16 750.49 1,074.11 1,379.96 784.97 557.39
Tax 291.00 223.95 197.20 244.98 137.98 119.90
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 3.74 20.84 16.46 -5.79 -5.47 0.00
Reported Net Profit 530.41 505.70 860.37 1,140.77 652.46 454.91
Extraordinary Items 822.16 750.49 1,074.11 1,379.96 784.97 557.39
Adjusted Net Profit 530.41 505.70 860.37 1,140.77 652.46 454.91
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 101.48 101.48 101.48 101.48 63.18 37.91
P & L Balance carried down 530.41 505.70 860.37 1,140.77 652.46 454.91
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 400.00 400.00 400.00 400.00 250.00 150.00
Dividend Per Share(Rs) 4.00 4.00 4.00 8.00 5.00 3.00
Earnings Per Share-Unit Curr 20.91 19.93 33.91 45.04 51.64 36.01
Book Value 101.48 101.48 101.48 101.48 63.18 37.91
Book Value(Adj)-Unit Curr 101.48 101.48 101.48 101.48 63.18 37.91

Shareholding Pattern

  • Promoter Group

    44.72%

  • Public Share Holding

    55.28%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 95,423,418 37.61 95,423,418 7
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 18,044,054 7.11 18,044,054 9
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 113,467,472 44.72 113,467,472 16
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 2,130 0.00 130 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 28,084,132 11.07 28,076,132 208
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 13,157,481 5.19 13,157,481 15
Mutual Funds / UTI 75,176,819 29.63 75,172,819 35
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 2,175,303 0.86 2,175,303 22
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 118,595,865 46.75 118,581,865 282
2] Non Institution
Bodies Corporate 1,148,342 0.45 1,143,342 549
Clearing Members 53,773 0.02 53,773 8
Directors of their Relatives 43,700 0.02 43,700 2
Employees 25,000 0.01 0 11
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 8,000 0.00 8,000 1
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,171,182 0.46 1,168,860 2,402
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 823,148 0.32 821,148 1,433
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 0 0.00 0 0
Individuals holding nominal share capital up to Rs. 1 lakh 17,449,140 6.88 16,708,614 85,404
Market Maker 2,000 0.00 2,000 1
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 16,877 0.01 16,877 6
Others 796,635 0.31 796,635 2
Sub Total 21,640,881 8.53 20,866,033 89,891
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 253,704,218 100.00 252,915,370 90,189

Company Background

Ipca Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Ipca Laboratories Ltd
  • BSE Code : 3617.0
  • ISIN : INE571A01038

  • Incorporation Year

    1949

  • Registered Office

    48 Kandivli Industrial Estate
    Kandivli (West), Mumbai,
    Maharashtra-400067

  • Telephone

    91-22-66474444

  • FAX

    91-22-28686613

  • Chairman

    Premchand Godha

  • Managing Director

    A K Jain

  • Company Secretary

    Harish P Kamath

  • Auditor

    Natvarlal Vepari & Co

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Ipca Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Ipca Labs. 1,496.85 6,277.75 6,166.46 48.65 14.12
Abbott India 29,940.35 6,097.18 5,848.91 47.68 44.71
Astrazeneca Phar 8,092.00 1,330.33 1,295.53 208.61 33.26
P & G Health Ltd 5,295.80 1,166.89 1,151.26 37.16 39.76
Glaxosmi. Pharma 2,857.90 3,530.73 3,407.25 56.83 44.44
Cipla 1,495.15 17,645.00 16,574.34 25.63 20.10
Amrutanjan Healt 666.30 437.58 421.23 39.06 20.84
Fermenta Biotec. 305.85 315.24 307.09 28.99 4.10
Guj. Themis Bio. 282.25 174.19 169.82 58.44 44.82
Bliss GVS Pharma 126.20 638.96 605.46 28.88 11.19
Ambalal Sarabhai 40.33 11.70 3.81 17.24 1.92